Paper Details
- Home
- Paper Details
Measurement of the subjective effects of methylphenidate in 11- to 15-year-old children with attention-deficit/hyperactivity disorder.
Author: BingcangChristopher, GuenthnerGreg, KellyThomas H, MartinCatherine A, RayensMary Kay
Original Abstract of the Article :
OBJECTIVE: This study examined subjective and other behavioral effects of methylphenidate (MPH) among adolescents. METHODS: Standard abuse liability assessment methods that have been used in adult populations were modified for attention-deficit/hyperactivity disorder (ADHD) adolescents. MPH effects...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/17343554
データ提供:米国国立医学図書館(NLM)
Methylphenidate's Subjective Effects on Adolescents with ADHD
Methylphenidate (MPH), a stimulant commonly used to treat Attention-Deficit/Hyperactivity Disorder (ADHD), can produce subjective effects that have been associated with drug abuse potential. This study investigated these subjective effects in adolescents with ADHD, employing standard abuse liability assessment methods. The results revealed that MPH, even at low doses, significantly influenced subjective ratings, suggesting potential concerns about its abuse liability in this population.
A Deeper Dive into ADHD Treatment
This study, like a camel navigating a sandy terrain, dives deep into the complexities of ADHD treatment, exploring the subtle effects of commonly prescribed medications. The findings raise important considerations regarding the potential for abuse and highlight the need for careful monitoring and management of stimulant medications in adolescents with ADHD.
Navigating ADHD Treatment: A Balanced Approach
This study emphasizes the need for a balanced approach to ADHD treatment, considering both the therapeutic benefits and the potential risks associated with stimulant medications. Open communication between healthcare professionals, parents, and individuals with ADHD is crucial for making informed decisions about treatment and ensuring safe and effective outcomes.
Dr.Camel's Conclusion
This study underscores the complexities of ADHD treatment and the importance of carefully considering the potential risks and benefits of stimulant medications. It's crucial for healthcare professionals and parents to approach treatment with a comprehensive and balanced perspective, ensuring the well-being and safety of individuals with ADHD.
Date :
- Date Completed 2007-05-30
- Date Revised 2019-01-08
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.